<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03337386</url>
  </required_header>
  <id_info>
    <org_study_id>MS/17.05.137</org_study_id>
    <nct_id>NCT03337386</nct_id>
  </id_info>
  <brief_title>Subclavian Versus Inferior Vena Cava Collapsibility Indices.</brief_title>
  <official_title>Reliability of Subclavian Vein Versus Inferior Vena Cava Collapsibility Indices for Preload Assessment.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Traditional methods for intravascular volume status assessment include physical examination,&#xD;
      raised leg test, central venous pressure (CVP) and pulmonary artery catheters occlusion&#xD;
      pressure (PAWP). Central venous pressure and pulmonary artery occlusion pressure are invasive&#xD;
      and associated with significant complications. More recently, a number of less invasive&#xD;
      techniques have been introduced, but they lack standardization and reliability.&#xD;
      Ultrasonically, inferior vena cava collapsibility can detect hypovolemia non-invasively.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is that measurement of subclavian vein collapsibility index(SCV-CI)&#xD;
      could be potential adjunct to IVC-CI where the IVC visualization is impaired or not possible&#xD;
      .&#xD;
&#xD;
      -Finding a non-invasive reliable accurate method for evaluation of intravascular volume and&#xD;
      response to volume resuscitation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 12, 2017</start_date>
  <completion_date type="Actual">May 20, 2018</completion_date>
  <primary_completion_date type="Actual">April 10, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>inferior vena cava collapsibility index changes</measure>
    <time_frame>intraoperative changes:1st basal before induction of anesthesia, 2nd before start of surgery, 3rd after10 ml/kg ringers preload, 4th 5 minutes before extubation.</time_frame>
    <description>ultrasound M mode maximum minus minimum over maximum then multiply by 100</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>subclavian vein collapsibility index changes</measure>
    <time_frame>intraoperative changes:1st basal before induction of anesthesia, 2nd before start of surgery, 3rd after 10 ml/kg ringers preload, 4th 5 minutes before extubation.</time_frame>
    <description>ultrasound M mode maximum minus minimum over the maximum then multiply by 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>central venous pressure changes</measure>
    <time_frame>intraoperative changes:1st basal before induction of anesthesia, 2nd before start of surgery, 3rd after 10 ml/kg ringers preload, 4th 5 minutes before extubation.</time_frame>
    <description>centimeter water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate changes</measure>
    <time_frame>intraoperative changes:1st basal before induction of anesthesia, 2nd before start of surgery, 3rd after 10 ml/kg ringers preload, 4th 5 minutes before extubation.</time_frame>
    <description>beat per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean blood pressure changes</measure>
    <time_frame>intraoperative changes:1st basal before induction of anesthesia, 2nd before start of surgery, 3rd after 10 ml/kg ringers preload, 4th 5 minutes before extubation.</time_frame>
    <description>millimeter mercury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fluid administration</measure>
    <time_frame>Intraoperative</time_frame>
    <description>milliliter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood loss</measure>
    <time_frame>intraoperative</time_frame>
    <description>milliliter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urine output</measure>
    <time_frame>intraoperative</time_frame>
    <description>milliliter</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>Inferior Vena Cava Collapsibility</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>inferior vena cava diameters is obtained in the supine position with a convex probe .The probe is placed in the subxiphoid region or the right anterior midaxillary plane.The sagittal section of IVC is imaged. M-mode probe is used to identify the measurement of minimum and maximum venous dimensions over the respiratory cycle using the 3.5-5 MHz phased array probe. To standardize the measurements, measuring of the IVC diameter is performed at 2 cm caudal of the junction point of the right atrium and IVC. The difference between the maximum (D max) and minimum (D min)diameters of the target vein is normalized according to the standard formula to yield the collapsibility index (CI).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subclavian Vein Collapsibility</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Right SCV diameters is checked in the supine position using a high frequency linear array probe (6-13 MHz) and M-mode. To standardize the measurements, the probe is placed beneath the proximal part of the middle part of the clavicle perpendicular to long-axis of the SCV to obtain the best cross-sectional view of the vien. After the target vein is localized , the dynamic diameter change is recorded using M-mode to identify and measure the minimum and maximum venous diameters.To calculate SCV collapsibility index, the standard formula is used.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>central venous pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ultrasound guided 7.5-F central venous catheter is introduced via right internal jugular vein under local analgesia with 2% lidocaine for measuring the CVP.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>inferior vena cava collapsibility</intervention_name>
    <description>inferior vena cava diameters is obtained in the supine position with a convex probe .The probe is placed in the subxiphoid region or the right anterior midaxillary plane.The sagittal section of IVC is imaged. M-mode probe is used to identify the measurement of minimum and maximum venous dimensions over the respiratory cycle using the 3.5-5 MHz phased array probe. To standardize the measurements, measuring of the IVC diameter is performed at 2 cm caudal of the junction point of the right atrium and IVC. The difference between the maximum (D max) and minimum (D min)diameters of the target vein is normalized according to the standard formula to yield the collapsibility index (CI).</description>
    <arm_group_label>Inferior Vena Cava Collapsibility</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>subclavian vein collapsibility</intervention_name>
    <description>Right SCV diameters is checked in the supine position using a high frequency linear array probe (6-13 MHz) and M-mode. To standardize the measurements, the probe is placed beneath the proximal part of the middle part of the clavicle perpendicular to long-axis of the SCV to obtain the best cross-sectional view of the vien. After the target vein is localized , the dynamic diameter change is recorded using M-mode to identify and measure the minimum and maximum venous diameters.To calculate SCV collapsibility index, the standard formula is used.</description>
    <arm_group_label>Subclavian Vein Collapsibility</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>central venous pressure</intervention_name>
    <description>ultrasound guided 7.5-F central venous catheter is introduced via right internal jugular vein under local analgesia with 2% lidocaine for measuring the CVP.</description>
    <arm_group_label>central venous pressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1. American society of anaesthesiologists physical status grade I and grade II .&#xD;
&#xD;
             2. Elective laparotomy. 3. Supine position&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient refusal .&#xD;
&#xD;
          2. Portal hypertension .&#xD;
&#xD;
          3. Severe peripheral vascular diseases.&#xD;
&#xD;
          4. Obstructive lung diseases .&#xD;
&#xD;
          5. Right sided heart failure , arrhythmia and valvular heart heart diseases .&#xD;
&#xD;
          6. Body mass index &gt;35 kg/m2&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oncolgy Center, Mansoura University,</name>
      <address>
        <city>Mansourah</city>
        <state>DK</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>November 3, 2017</study_first_submitted>
  <study_first_submitted_qc>November 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2017</study_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Alaa Mazy Mazy</investigator_full_name>
    <investigator_title>Associate professor of anesthesia and surgical intensive care</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

